{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:05:46Z","timestamp":1790010346174,"version":"4.0.1"},"reference-count":48,"publisher":"Bioscientifica","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although uncommon, thyroid nodules (TNs) in pediatric and young adult patients carry a higher malignancy risk and often present with a high burden of metastatic disease than in adults. The molecular features underlying this distinct clinical behavior remain unclear. We analyzed Afirma Genomic Sequencing Classifier (GSC) data from 283,621 TNs, comparing patients &amp;lt;21 and \u226521 years old. Cytology (Bethesda), GSC benign (B) vs suspicious (S) calls, and Afirma Xpression Atlas (XA) variant\/fusion profiles were evaluated in GSC-S and Bethesda V\/VI samples. Genome-wide expression was used to derive pathway signatures and thyroid cancer-related scores: BRAF-RAS score (BRS), ERK signaling score, follicular-to-mesenchymal transition (FMT) score, epithelial-to-mesenchymal transition (EMT) score, and thyroid differentiation score (TDS). Among 2,397 patients &amp;lt;21 years (median age: 18.9; 81.4% female) and 281,224 adults \u226521 years (median age: 59.8; 77.1% female), the &amp;lt;21-year samples showed more Bethesda V\/VI cytology (14.5% vs 5.0%; P &amp;lt; 0.0001) and a lower GSC-B rate (43.5% vs 68.8%; P &amp;lt; 0.0001). In GSC-S samples, total variant detection was higher in the &amp;lt;21-year group (45.3% vs 37.4%), with enriched BRAF p.V600E, TSHR, and DICER1 variants, while HRAS variants were more common in adults (all P &amp;lt; 0.01). Gene fusions involving RET, NTRK3, and ALK were enriched in the &amp;lt;21-year group (14.5% vs 5.5%; P &amp;lt; 0.0001). TERT promoter mutations were absent in &amp;lt;21-year GSC-S and Bethesda V\/VI samples (vs 4.2% and 9.3% in adults). The GSC-S &amp;lt;21-year cohort showed cell-cycle pathway enrichment. The RET\/NTRK\/ALK-positive &amp;lt;21-year group demonstrated enrichment of angiogenesis and EMT pathways, higher ERK\/EMT\/FMT scores, and lower BRS\/TDS vs genotyped-matched adults. These molecular differences provide mechanistic insight into the more invasive phenotype in pediatric and young adult TNs.<\/jats:p>","DOI":"10.1530\/erc-26-0115","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:19:54Z","timestamp":1788797994000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Distinct molecular profiles of indeterminate and malignant thyroid nodules in patients under 21 years of age"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-6869","authenticated-orcid":true,"given":"Julio C","family":"Ricarte-Filho","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children\u2019s Hospital of Philadelphia 1 , , ,","place":["Philadelphia, Pennsylvania, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Castellanos","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center 2 , , ,","place":["Houston, Texas, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-0100","authenticated-orcid":true,"given":"Steven G","family":"Waguespack","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center 2 , , ,","place":["Houston, Texas, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Bryan","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics Laboratory, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center 3 , , ,","place":["Houston, Texas, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshalalfa","sequence":"additional","affiliation":[{"name":"Veracyte, Inc. 4 , , ,","place":["South San Francisco, California, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor B","family":"Cavazos","sequence":"additional","affiliation":[{"name":"Veracyte, Inc. 4 , , ,","place":["South San Francisco, California, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[{"name":"Veracyte, Inc. 4 , , ,","place":["South San Francisco, California, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bauer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children\u2019s Hospital of Philadelphia 1 , , ,","place":["Philadelphia, Pennsylvania, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P","family":"Klopper","sequence":"additional","affiliation":[{"name":"Veracyte, Inc. 4 , , ,","place":["South San Francisco, California, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T","family":"Kloos","sequence":"additional","affiliation":[{"name":"Veracyte, Inc. 4 , , ,","place":["South San Francisco, California, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5228","authenticated-orcid":true,"given":"Aime T","family":"Franco","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Thyroid Center, Children\u2019s Hospital of Philadelphia 1 , , ,","place":["Philadelphia, Pennsylvania, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026092112164744000_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/cen.12786","article-title":"Accuracy of thyroid nodule sonography for the detection of thyroid cancer in children: systematic review and meta-analysis","volume":"84","author":"Al Nofal","year":"2016","journal-title":"Clin Endocrinol"},{"key":"2026092112164744000_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00268-017-4279-x","article-title":"Papillary Thyroid carcinoma (PTC) in children and adults: comparison of initial presentation and long-term postoperative outcome in 4432 patients consecutively treated at the Mayo clinic during eight decades (1936-2015)","volume":"42","author":"Hay","year":"2018","journal-title":"World J Surg"},{"key":"2026092112164744000_bib3","doi-asserted-by":"crossref","first-page":"e1683","DOI":"10.1210\/clinem\/dgaa935","article-title":"Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape","volume":"106","author":"Nies","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2265.1998.00584.x","article-title":"Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults","volume":"49","author":"Welch Dinauer","year":"1998","journal-title":"Clin Endocrinol"},{"key":"2026092112164744000_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"key":"2026092112164744000_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026092112164744000_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2026092112164744000_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"2026092112164744000_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.21.01861","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026092112164744000_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Invest"},{"key":"2026092112164744000_bib11","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","journal-title":"Cancer Res"},{"key":"2026092112164744000_bib12","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","article-title":"BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer","volume":"90","author":"Xing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","article-title":"The prevalence and prognostic value of BRAF mutation in thyroid cancer","volume":"246","author":"Kebebew","year":"2007","journal-title":"Ann Surg"},{"key":"2026092112164744000_bib14","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1002\/lary.24668","article-title":"BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma","volume":"124","author":"Givens","year":"2014","journal-title":"Laryngoscope"},{"key":"2026092112164744000_bib15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/pbc.24935","article-title":"BRAF V600E mutational status in pediatric thyroid cancer","volume":"61","author":"Henke","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2026092112164744000_bib16","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1245\/s10434-025-16963-0","article-title":"Questioning the role of BRAF V600E as a prognostic indicator in papillary thyroid carcinoma","volume":"32","author":"Javid","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"2026092112164744000_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel","year":"2018","journal-title":"JAMA Surg"},{"key":"2026092112164744000_bib18","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1210\/clinem\/dgag059","article-title":"Afirma genomic sequencing classifier performance in young patients with cytologically indeterminate thyroid nodules","volume":"111","author":"Castellanos","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jpm13010024","article-title":"Maximizing small biopsy patient samples: unified RNA-seq platform assessment of over 120,000 patient biopsies","volume":"13","author":"Walsh","year":"2022","journal-title":"J Pers Med"},{"key":"2026092112164744000_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2018.0733","article-title":"Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules","volume":"29","author":"Endo","year":"2019","journal-title":"Thyroid"},{"key":"2026092112164744000_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/thy.2024.0254","article-title":"Cytologic and molecular assessment of isthmus thyroid nodules and carcinomas","volume":"35","author":"Jasim","year":"2025","journal-title":"Thyroid"},{"key":"2026092112164744000_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1073592","article-title":"Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations","volume":"13","author":"Whitmer","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026092112164744000_bib23","first-page":"1039","article-title":"The 2023 bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"2026092112164744000_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fendo.2019.00612","article-title":"Analytical and clinical validation of expressed variants and fusions from the whole transcriptome of thyroid FNA samples","volume":"10","author":"Angell","year":"2019","journal-title":"Front Endocrinol"},{"key":"2026092112164744000_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2026092112164744000_bib26","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026092112164744000_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1677\/erc.1.00882","article-title":"Pathogenesis, diagnosis and management of thyroid nodules in children","volume":"13","author":"Niedziela","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"2026092112164744000_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1148\/radiol.2018171170","article-title":"Thyroid nodules in pediatric patients: sonographic characteristics and likelihood of cancer","volume":"288","author":"Richman","year":"2018","journal-title":"Radiology"},{"key":"2026092112164744000_bib29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Consortium APG","year":"2017","journal-title":"Cancer Discov"},{"key":"2026092112164744000_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/cancers17010107","article-title":"The impact of radioactive iodine on outcomes among pediatric and adolescent thyroid cancer patients: a SEER database analysis","volume":"17","author":"Persons","year":"2025","journal-title":"Cancers"},{"key":"2026092112164744000_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00383-025-05990-3","article-title":"Clinical characteristics, surgical approaches, and prognosis of follicular and papillary thyroid cancer in children and adolescents: a retrospective cohort study","volume":"41","author":"Liu","year":"2025","journal-title":"Pediatr Surg Int"},{"key":"2026092112164744000_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2026092112164744000_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2005.01.017","article-title":"Focus on lymphangiogenesis in tumor metastasis","volume":"7","author":"Achen","year":"2005","journal-title":"Cancer Cell"},{"key":"2026092112164744000_bib34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"2026092112164744000_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2020.0002","article-title":"Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy","volume":"31","author":"Chesover","year":"2021","journal-title":"Thyroid"},{"key":"2026092112164744000_bib36","doi-asserted-by":"crossref","first-page":"e3981","DOI":"10.1210\/clinem\/dgaa545","article-title":"Distant metastasis in pediatric and adolescent differentiated thyroid cancer: clinical outcomes and risk factor analyses","volume":"105","author":"Sugino","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib37","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf070","article-title":"Distant metastases and outcome of pediatric differentiated thyroid cancer","volume":"9","author":"Alzahrani","year":"2025","journal-title":"J Endocr Soc"},{"key":"2026092112164744000_bib38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/clinem\/dgab851","article-title":"Characterization of subtypes of BRAF-mutant papillary thyroid cancer defined by their thyroid differentiation score","volume":"107","author":"Boucai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib39","article-title":"Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026092112164744000_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000044540","article-title":"Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer","volume":"104","author":"Nhung","year":"2025","journal-title":"Medicine"},{"key":"2026092112164744000_bib41","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer","volume":"99","author":"Liu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.2015.0510","article-title":"Uncommon TERT promoter mutations in pediatric thyroid cancer","volume":"26","author":"Alzahrani","year":"2016","journal-title":"Thyroid"},{"key":"2026092112164744000_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/thy.2016.0350","article-title":"Effects of coexistent BRAF(V600E) and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: a meta-analysis","volume":"27","author":"Moon","year":"2017","journal-title":"Thyroid"},{"key":"2026092112164744000_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/modpathol.3800235","article-title":"Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors","volume":"18","author":"Prasad","year":"2005","journal-title":"Mod Pathol"},{"key":"2026092112164744000_bib45","doi-asserted-by":"crossref","first-page":"E890","DOI":"10.1210\/jc.2014-4053","article-title":"High diagnostic accuracy based on CLDN10, HMGA2, and LAMB3 transcripts in papillary thyroid carcinoma","volume":"100","author":"Barros-Filho","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092112164744000_bib46","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/ijms26041643","article-title":"HMGA2 overexpression in papillary thyroid cancer promotes thyroid cell dedifferentiation and invasion, and these effects are counteracted by suramin","volume":"26","author":"Van Branteghem","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026092112164744000_bib47","first-page":"927","article-title":"BRAF(V600E)-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"2026092112164744000_bib48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jamaoncol.2022.1655","article-title":"Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children","volume":"8","author":"Gallant","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0115\/524996\/erc-26-0115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0115\/524996\/erc-26-0115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:17:09Z","timestamp":1790007429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/9\/e260115\/78165\/Distinct-molecular-profiles-of-indeterminate-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0115","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"e260115"}}